A
Agnes Brennan
Researcher at Harvard University
Publications - 4
Citations - 438
Agnes Brennan is an academic researcher from Harvard University. The author has contributed to research in topics: Antigen & Cytotoxic T cell. The author has an hindex of 4, co-authored 4 publications receiving 436 citations.
Papers
More filters
Journal ArticleDOI
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
Thierry Hercend,James D. Griffin,Armand Bensussan,R E Schmidt,Mary Ann Edson,Agnes Brennan,Christopher J L Murray,Jennifer Daley,Stuart F. Schlossman,Jerome Ritz +9 more
TL;DR: Results strongly supported the view that NKH1A is a "pan-NK" associated antigen, and indicated that at least a fraction of cloned NKH2 + LGL are strongly cytotoxic.
Journal ArticleDOI
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
Thierry Hercend,Stefan Meuer,Agnes Brennan,Mary Ann Edson,Oreste Acuto,Ellis L. Reinherz,Stuart F. Schlossman,Jerome Ritz +7 more
TL;DR: The present data suggest that the specificity of one population of human NK active lymphocytes is determined by clonotypic structures.
Journal ArticleDOI
Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines.
Thierry Hercend,Thierry Hercend,R E Schmidt,Agnes Brennan,Mary Ann Edson,Ellis L. Reinherz,Stuart F. Schlossman,Jerome Ritz +7 more
TL;DR: Analysis of the functional effects of anti‐ TNKTAR indicated that alteration of the cytotoxic reactions resulted from the binding of the antibody to the membrane of target cells, and it was shown that inhibition of cytotoxicity induced by anti‐TNKTAR could be abolished by lectin approximation.
Journal ArticleDOI
Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure.
Thierry Hercend,Stefan Meuer,Agnes Brennan,Mary Ann Edson,Oreste Acuto,Ellis L. Reinherz,Stuart F. Schlossman,Jerome Ritz +7 more
TL;DR: The selective blocking effect of anti-NKTb supports the notion that the heterodimer defined by the NKT antibodies is involved in the process of target cell recognition rather than in the cytolytic pathway of the cloned effector cells.